NCT04452955: A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 51 taking part
- Started
- 12 Dec 2020
- Primary completion
- 1 Dec 2026
- Arms
- PRL3-zumab
- Results
- None posted
- 1 Jul 2020: Trial registered
- 12 Dec 2020: Trial started